These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 7754837)
1. Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma. Kuratsu JI; Seto H; Kochi M; Ushio Y Acta Neurochir (Wien); 1994; 131(3-4):289-93. PubMed ID: 7754837 [TBL] [Abstract][Full Text] [Related]
2. The molecular biology of hormone and growth factor receptors in meningiomas. Black P; Carroll R; Zhang J Acta Neurochir Suppl; 1996; 65():50-3. PubMed ID: 8738495 [TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor expression and stimulation in human meningiomas. Black PM; Carroll R; Glowacka D; Riley K; Dashner K J Neurosurg; 1994 Sep; 81(3):388-93. PubMed ID: 8057146 [TBL] [Abstract][Full Text] [Related]
4. Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas. Yang SY; Xu GM J Clin Neurosci; 2001 May; 8 Suppl 1():49-53. PubMed ID: 11386826 [TBL] [Abstract][Full Text] [Related]
6. Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Maxwell M; Galanopoulos T; Hedley-Whyte ET; Black PM; Antoniades HN Int J Cancer; 1990 Jul; 46(1):16-21. PubMed ID: 2163990 [TBL] [Abstract][Full Text] [Related]
7. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. Pravdenkova S; Al-Mefty O; Sawyer J; Husain M J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818 [TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor (PDGF) and receptor (PDGFR) expression in human meningiomas: correlations with clinicopathological features and cytogenetic analysis. Figarella-Branger D; Vagner-Capodano AM; Bouillot P; Graziani N; Gambarelli D; Devictor B; Zattara-Cannoni H; Bianco N; Grisoli F; Pellissier JF Neuropathol Appl Neurobiol; 1994 Oct; 20(5):439-47. PubMed ID: 7531297 [TBL] [Abstract][Full Text] [Related]
9. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha. Yoshida K; Kuniyasu H; Yasui W; Kitadai Y; Toge T; Tahara E J Cancer Res Clin Oncol; 1993; 119(7):401-7. PubMed ID: 8491760 [TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical study of progesterone receptor in human meningioma. Perrot-Applanat M; Groyer-Picard MT; Kujas M Acta Neurochir (Wien); 1992; 115(1-2):20-30. PubMed ID: 1595392 [TBL] [Abstract][Full Text] [Related]
11. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Peyre M; Salaud C; Clermont-Taranchon E; Niwa-Kawakita M; Goutagny S; Mawrin C; Giovannini M; Kalamarides M Oncotarget; 2015 Oct; 6(32):32713-22. PubMed ID: 26418719 [TBL] [Abstract][Full Text] [Related]
12. Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. Schrell UM; Adams EF; Fahlbusch R; Greb R; Jirikowski G; Prior R; Ramalho-Ortigao FJ J Neurosurg; 1990 Nov; 73(5):743-9. PubMed ID: 2213164 [TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha inhibits the DNA synthesis induced by PDGF and EGF in cultured meningioma cells. Zhang ZJ; Muhr C; Wang JL Anticancer Res; 1996; 16(2):717-23. PubMed ID: 8687119 [TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas. Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792 [TBL] [Abstract][Full Text] [Related]
16. New Insights into Expression of Hormonal Receptors by Meningiomas. Portet S; Banor T; Bousquet J; Simonneau A; Flores M; Ingrand P; Milin S; Karayan-Tapon L; Bataille B World Neurosurg; 2020 Aug; 140():e87-e96. PubMed ID: 32371078 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: Part II--Additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements. Jensen RL; Lee YS; Guijrati M; Origitano TC; Wurster RD; Reichman OH Neurosurgery; 1995 Nov; 37(5):937-46; discussion 946-7. PubMed ID: 8559343 [TBL] [Abstract][Full Text] [Related]
19. Control of meningioma cell growth by platelet-derived growth factor (PDGF). Mauro A; Di Sapio A; Mocellini C; Schiffer D J Neurol Sci; 1995 Aug; 131(2):135-43. PubMed ID: 7595638 [TBL] [Abstract][Full Text] [Related]
20. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]